The short answer#
PMS and PMDD sit on the same spectrum, but they are not the same thing. PMS covers the common physical and mood symptoms that show up in the week or two before a period and settle once bleeding starts. PMDD, premenstrual dysphoric disorder, is a distinct and more severe condition in which mood symptoms (irritability, sudden mood swings, low mood, or anxiety) become intense enough to disrupt work, school, or relationships in most cycles. The dividing lines are severity, functional impairment, and a strictly cyclic pattern confirmed by daily symptom tracking. PMDD affects roughly 3% to 8% of people who menstruate, and it responds to treatment.
Key points#
- Same spectrum, different weight. PMS is common and usually manageable. PMDD is a defined disorder with marked impairment.
- Timing is the signature. Symptoms cluster in the luteal phase (the week or two before menses) and ease within a few days of bleeding starting, followed by a symptom-free stretch.
- DSM-5 sets a bar for PMDD: at least 5 of 11 listed symptoms, including at least one core mood symptom, causing significant distress or loss of function.
- Diagnosis relies on prospective daily ratings across at least two cycles, not memory. Charting separates PMDD from a mood or anxiety disorder that flares premenstrually.
- SSRIs are the best-studied treatment for PMDD. A 2024 Cochrane review found they probably reduce symptoms, with continuous daily dosing somewhat more effective than luteal-only dosing.
- Lifestyle steps, cognitive behavioral therapy, and some hormonal options have a role. The evidence for most supplements is weaker.
- Symptoms that never fully clear, low mood present all month, or any thought of self-harm need prompt evaluation.
What is the difference between PMS and PMDD?#
Nearly everyone who menstruates notices something in the days before a period: bloating, breast tenderness, headache, food cravings, tiredness, or a shorter temper. Surveys suggest most people report at least mild premenstrual symptoms, and a smaller share have symptoms troublesome enough to interfere with daily life. That everyday, physical-plus-mild-mood picture is what clinicians mean by PMS.
PMDD is a step change, not just a bad case of PMS. In PMDD the emotional symptoms dominate and become severe: pronounced irritability or anger, mood swings that feel out of your control, hopeless or low mood, and anxiety or tension. What makes it a disorder rather than a rough week is impairment. The symptoms repeatedly damage function, straining relationships, derailing work or school, and pushing daily life off track, then lifting after the period arrives.
Three features do most of the sorting work: severity, timing, and function.
| Feature | Typical PMS | PMDD |
|---|---|---|
| Timing | Luteal week or two before menses, eases after bleeding starts | Same cyclic timing, confirmed by charting |
| Leading symptoms | Physical symptoms plus mild mood changes | Severe mood symptoms (irritability, mood swings, low mood, anxiety) |
| Number of symptoms | One or more | At least 5, including one core mood symptom |
| Effect on function | Annoying but manageable | Marked impairment in work, school, or relationships |
| How it is confirmed | Clinical pattern | DSM-5 criteria plus two cycles of daily ratings |
This topic is part of our wider section on Women's, men's, and reproductive health, where premenstrual conditions overlap with contraception, mood, and general primary care.
What are the symptoms of PMDD?#
The DSM-5 framework asks for at least 5 of 11 symptoms during the final week before menses, with the symptoms improving within a few days of bleeding and largely gone in the week after the period. At least one has to be a core mood symptom:
- Marked mood swings or sudden tearfulness
- Marked irritability, anger, or increased conflict
- Depressed mood, hopelessness, or self-critical thoughts
- Marked anxiety, tension, or feeling on edge
The remaining symptoms fill out the picture and can include reduced interest in usual activities, trouble concentrating, low energy or marked fatigue, changes in appetite or specific food cravings, sleeping too much or too little, a sense of being overwhelmed or out of control, and physical symptoms such as breast tenderness, bloating, joint or muscle aches, or a feeling of weight gain.
Two details matter. First, the count is not a checklist you tally once. The symptoms have to cluster in the luteal phase and cause real distress or interfere with function. Second, PMDD is defined by cyclicity. If low mood or anxiety is present most of the month and simply worsens before a period, that pattern is a premenstrual exacerbation of an underlying condition, not PMDD, and it points toward evaluating for depression or an anxiety disorder. Our guide Depression and Anxiety in Primary Care: What to Expect covers how those conditions are assessed.
How do symptom diaries confirm the pattern?#
Memory is a poor witness here. When people rate their symptoms from recall, the timing blurs, and conditions that run all month can look premenstrual. That is why current guidance leans on prospective daily ratings: you score a short list of symptoms each day for at least two consecutive cycles, then look at whether the peaks really do land in the luteal phase and clear after menses.
Validated tools exist for exactly this. The Daily Record of Severity of Problems (DRSP) tracks the DSM-5 symptoms day by day, and screening instruments such as the Premenstrual Symptom Screening Tool (PSST) help flag who should chart. The point of charting is not paperwork. It is the single step that most reliably distinguishes PMDD from a primary mood or anxiety disorder, from thyroid problems, and from ordinary PMS.
Because PMDD shares so much ground with depression and anxiety, clinicians often pair the diary with standard mood screens. The instruments described in Mental Health Screening Tools: PHQ-9 and GAD-7 Explained can show whether symptoms are truly confined to the luteal phase or are present, at some level, throughout the month. That distinction changes what treatment makes sense.
How is PMDD treated?#
At an educational level, the evidence is strongest for two approaches: SSRIs and structured self-management, often used together. Nothing below is a prescription. It is a map of what trials and guidelines describe so you can have a better conversation with a clinician.
SSRIs (a class of antidepressants) are the best-studied option for PMDD. A 2024 Cochrane review pooling 34 randomized trials in about 4,500 women concluded that SSRIs probably reduce overall premenstrual symptoms, a moderate effect on symptom scales. They can be taken two ways: every day (continuous), or only during the luteal phase, from around ovulation until the period starts (intermittent). The Cochrane analysis found continuous dosing probably works somewhat better than luteal-only dosing. Because SSRIs can act on premenstrual mood within days rather than the weeks needed in depression, the intermittent schedule is a genuine option for some people. Side effects are real: in the pooled trials nausea affected about 1 in 5 users (roughly 20%, versus 7% on placebo) and low energy or fatigue about 1 in 7 (roughly 14%, versus 5% on placebo), with insomnia and sexual side effects also more common than on placebo. That trade-off, faster relief against tolerability, is worth weighing openly.
Combined hormonal contraceptives are the other prescription route people ask about, particularly formulations containing drospirenone, sometimes taken continuously to avoid a monthly hormone drop. The benefit for premenstrual mood symptoms has looked modest and inconsistent in trials, so it is better framed as an option to discuss than a sure fix, especially if contraception is wanted anyway. Our guide Contraception in Primary Care: Methods and How to Choose walks through how these methods are selected.
Non-drug measures carry little downside and belong in most plans. Regular aerobic exercise, protected sleep, and stress reduction are standard advice, and cognitive behavioral therapy has evidence for premenstrual mood symptoms without medical harms. Among supplements, calcium and vitamin B6 are the most commonly cited, but the evidence is limited, and popular herbal products such as chasteberry rest on weaker data. Check with a clinician or pharmacist before starting any supplement, since some interact with medications.
When to seek care#
Some situations call for a clinician sooner rather than later, and one calls for urgent help now.
- Any thoughts of suicide or self-harm. Do not wait for the next cycle. In the US you can call or text 988 for the Suicide and Crisis Lifeline, or use local emergency services. PMDD is associated with a raised risk of suicidal thoughts, and this symptom is always a reason to reach out immediately.
- Symptoms that do not fully lift after your period, or low mood and anxiety present most of the month. This pattern points toward a primary mood or anxiety condition rather than PMDD and deserves its own assessment.
- Premenstrual symptoms that repeatedly disrupt work, school, parenting, or relationships. Impairment is the threshold that separates a treatable disorder from an ordinary rough patch.
- Symptoms that are not improving after a few cycles of first-line measures, so the plan can be adjusted.
- New, severe, or worsening symptoms, or premenstrual mood changes appearing for the first time in the years around menopause, which merit a broader check.
For a diagnosis or a treatment plan tailored to you, see a qualified clinician who can review your full history.
Sources and further reading
- Premenstrual Dysphoric Disorder (StatPearls, NCBI Bookshelf)
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder (Cochrane Review, 2024)
- Benefits and risks of treating PMS and PMDD with SSRIs (Cochrane plain-language summary)
- Premenstrual syndrome (PMS) (NHS)
- Premenstrual syndrome (PMS) (Office on Women's Health)